Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer screening.

F E Alexander1

  • 1Department of Public Health Sciences, University of Edinburgh, Edinburgh, EH8 9AG, United Kingdom. freda.alexander@ed.ac.uk

Microscopy Research and Technique
|November 14, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology of Non-Hodgkin's Lymphoma in Parts of England and Wales (1984-1988).

Leukemia & lymphoma·2016
Same author

Yorkshire Case Control Study of Leukaemias and Lymphomas Parallel Multivariate Analyses of Seven Disease Categories.

Leukemia & lymphoma·2016
Same author

Phyto-oestrogens and risk of prostate cancer in Scottish men.

The British journal of nutrition·2007
Same author

Measles virus and classical Hodgkin lymphoma: no evidence for a direct association.

International journal of cancer·2007
Same author

Phyto-oestrogen intake in Scottish men: use of serum to validate a self-administered food-frequency questionnaire in older men.

European journal of clinical nutrition·2005
Same author

Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study.

BMJ (Clinical research ed.)·2005
Same journal

Deep Learning Based Framework for Detection and Classification of Leukemia Using Microscopic Images.

Microscopy research and technique·2026
Same journal

Externally Controlled In Situ SEM: Multi-Rate Scanning With Signal Regulation and Spatiotemporal Fusion.

Microscopy research and technique·2026
Same journal

In Situ TEM Observation of Phase Transformation Nucleation at the Near-Surface of Synthetic Aragonite.

Microscopy research and technique·2026
Same journal

Morpho-Anatomical and HPTLC Investigations of Lysimachia nummularia L. (Primulaceae) Grown in Switzerland.

Microscopy research and technique·2026
Same journal

Macroscopic, Histological and Ultrastructural Features of the Tongue of the Anatolian Wild Boar (Sus scrofa libycus).

Microscopy research and technique·2026
Same journal

Ultrastructural Insights Into the Reproductive Anatomy and Eggs of Cotton Pink Bollworm, Pectinophora gossypiella Saunders (Lepidoptera: Gelechiidae).

Microscopy research and technique·2026
See all related articles

Prostate cancer screening using prostate-specific antigen (PSA) testing can detect early-stage cancers. Randomized controlled trials (RCTs) are essential to confirm if PSA screening effectively reduces prostate cancer mortality.

Area of Science:

  • Oncology
  • Public Health
  • Medical Screening

Background:

  • Prostate cancer represents a significant and increasing public health concern.
  • Prostate-specific antigen (PSA) testing enables early detection of asymptomatic prostate cancer cases.
  • Screening programs hold the potential to substantially decrease prostate cancer mortality.

Purpose of the Study:

  • To evaluate the necessity and reliability of evidence for prostate cancer screening programs.
  • To emphasize the critical role of randomized controlled trials (RCTs) in validating screening efficacy.
  • To compare evidence from alternative sources against RCTs for prostate cancer screening.

Main Methods:

  • Review and comparison of evidence from various sources for prostate cancer screening.

Related Experiment Videos

  • Focus on the methodological rigor of randomized controlled trials (RCTs).
  • Assessment of the potential consequences of making incorrect decisions regarding screening strategies.

    • Main Results:

    • PSA testing identifies numerous asymptomatic prostate cancer cases, offering potential mortality reductions.
    • Randomized controlled trials (RCTs) are identified as the most reliable source of evidence for screening effectiveness.
    • The high cost of erroneous decisions underscores the importance of robust evidence.

    Conclusions:

    • The evidence strongly supports the use of randomized controlled trials (RCTs) to ascertain the benefits of prostate cancer screening programs.
    • The potential benefits of PSA screening in reducing mortality are significant but require definitive validation through RCTs.
    • Given the high stakes, the case for conducting RCTs to guide prostate cancer screening policy is compelling.